Pharmaceutical Market Europe • December 2022 • 3

COMMENT

Sustainability and corporate social responsibility

In this issue, our cover article by Danny Buckland focuses on pharma’s vital role in sustainability and corporate social responsibility. As global companies outlined decarbonisation plans across active pharmaceutical ingredient supply chains at COP27, the Lancet Countdown 2022 Report stated: ‘The world faces a critical juncture. A health-centred, aligned response to the compounding crises can still deliver a future where people can not only survive, but thrive.’

As Danny says: ‘It is now clear that devising corporate social responsibility programmes aligned solely to an organisation’s therapy areas or narrow corporate responsibilities will not be enough.

‘If the pharma industry was a country, it would be the fifth largest emitter of carbon on the earth, and it is facing the glare of scrutiny lasering into every process and action that could influence its impact on the health of society – and the health of the planet.

‘How organisations tackle these challenges – alongside the day job of discovering, developing, manufacturing and getting therapies to patients – is having an increasing effect on their ability to function, connect with HCPs, identify with patients, attract investors and build a brand reputation with the wider public. It is a mountainous task even for an industry that thrives on facing and overcoming the intractable.’ Read more on page 32.

Also in this month’s issue, Paul Chew, Chief Medical Office at Phesi, talks about addressing the diversity issue in clinical trials and how patient-centric analytics can be used to design more diverse, inclusive and equitable trials. Turn to page 18 to find out more.

Looking ahead, our January issue will focus on innovation in digital healthcare and how remote monitoring is improving patient outcomes.

If you would like to make your voice heard on these topics, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Journalist/editorial assistant
Fleur Jeffries
Emily Kimber


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2022 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image